Skip navigation
Veuillez utiliser cette adresse pour citer ce document : http://repositorio.unb.br/handle/10482/51884
Fichier(s) constituant ce document :
Il n'y a pas de fichiers associés à ce document.
Affichage complet
Élément Dublin CoreValeurLangue
dc.contributor.authorTeixeira, Tamara-
dc.contributor.authorRibeiro, Gabriel H.-
dc.contributor.authorGonçalves, Guilherme R.-
dc.contributor.authorAraújo Neto, João Honorato de-
dc.contributor.authorOliveira, Katia Mara de-
dc.contributor.authorCorrea, Rodrigo S.-
dc.date.accessioned2025-03-13T21:18:33Z-
dc.date.available2025-03-13T21:18:33Z-
dc.date.issued2024-04-22-
dc.identifier.citationTEIXEIRA, Tamara et. al. Selective Ru(II)/benzoate complexes against triple-negative breast tumor cells and their interactions with DNA and BSA. Inorganica Chimica Acta, v. 568, art. 122078, 1 ago. 2024. DOI 10.1016/j.ica.2024.122078. Disponível em: https://www.sciencedirect.com/science/article/pii/S0020169324001683?via%3Dihub. Acesso em: 13 mar. 2025.pt_BR
dc.identifier.urihttp://repositorio.unb.br/handle/10482/51884-
dc.language.isoengpt_BR
dc.publisherElsevierpt_BR
dc.rightsAcesso Restritopt_BR
dc.titleSelective Ru(II)/benzoate complexes against triple-negative breast tumor cells and their interactions with DNA and BSApt_BR
dc.typeArtigopt_BR
dc.subject.keywordRutêniopt_BR
dc.subject.keywordElementos químicos - atividade citotóxicapt_BR
dc.subject.keywordMamas - câncer - tratamentopt_BR
dc.rights.license© 2024 Elsevier B.V. All rights reserved.pt_BR
dc.identifier.doihttps://doi.org/10.1016/j.ica.2024.122078pt_BR
dc.relation.publisherversionhttps://www.sciencedirect.com/science/article/pii/S0020169324001683?via%3Dihubpt_BR
dc.description.abstract1New ruthenium(II) complexes bearing benzoate (AB) ligand with the general formula [Ru(AB)(bipy)(P–P)]PF6, where 2,2′-bipyridine (bipy) and different diphosphine ligands, (P–P) = 1,2′-bis(diphenylphosphine)ethane(dppe, 1), 1,3′-bis(diphenylphosphine)propane (dppp, 2) and 1,2′-bis(diphenylphosphine)ferrocene (dppf, 3), were synthesized. The compounds were characterized by molar conductivity, elemental analysis, cyclic voltammetry, infrared and UV–Vis spectroscopies, NMR, and by single-crystal X-ray diffraction for complexes 1 and 2. The complexes showed a weak interaction to CT-DNA through DNA minor groove, with Kb values at around 103-104 M− 1. CT-DNA interaction assays by viscosity and circular dichroism (CD) suggested that the compounds do not significantly alter the secondary DNA structure. The complexes are cytotoxic against MDA-MB-231, MCF7 (breast) and A549 (lung) tumor cell lines, with IC50 values in the range of 1 to 17 µM. The compounds 1-3 showed high selectivity against triple-negative breast tumor cells. Remarkably, complexes 1 and 3 show greater cytotoxic activity against cells than cisplatin, being promising agents for tumor treatment.pt_BR
dc.identifier.orcidhttps://orcid.org/0000-0002-1127-6083pt_BR
dc.identifier.orcidhttps://orcid.org/0000-0003-4749-0281pt_BR
dc.contributor.emailmailto:tamarateixeira@estudante.ufscar.brpt_BR
dc.contributor.affiliationChemistry Department, ICEB, Federal University of Ouro Preto – UFOPpt_BR
dc.contributor.affiliationEmbrapapt_BR
dc.contributor.affiliationChemistry Department, ICEB, Federal University of Ouro Preto – UFOPpt_BR
dc.contributor.affiliationPhysics Institute of São Carlos, University of São Paulo – USPpt_BR
dc.contributor.affiliationUniversidade de Brasíliapt_BR
dc.contributor.affiliationhttps://orcid.org/0000-0003-2783-0816pt_BR
dc.description.unidadeInstituto de Químicapt_BR
Collection(s) :Artigos publicados em periódicos e afins

Affichage abbrégé " class="statisticsLink btn btn-primary" href="/handle/10482/51884/statistics">



Tous les documents dans DSpace sont protégés par copyright, avec tous droits réservés.